Recruiting

Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy

This pilot study will examine the effects of a digital health approach, Moms@Home, on home blood pressure monitoring in a diverse population of pregnant women with hypertension.

ClinicalTrials.gov IDNCT06835959
PhaseNA
Enrollment100
SponsorUniversity of Massachusetts, Worcester
Age18 Years
SexFEMALE
I'm interested View official listing

Conditions studied

Hypertension in Pregnancy, Chronic Hypertension, Gestational Hypertension

About this study

This pilot study will examine the effects of a digital health approach, Moms@Home, on home blood pressure monitoring in a diverse population of pregnant women with hypertension.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Age 18-50 * English or Spanish speaking * A diagnosis of gestational (20-26 weeks gestational age) or chronic hypertension (8-26 weeks gestational age) * Singleton or multiple gestation pregnancy, * A patient of the University of Massachusetts Memorial Health Obstetrics/Maternal and Fetal Medicine clinics in Worcester, Massachusetts * Willing to share home blood pressure monitoring data * Comfortable with the use of smartphones and mobile apps Exclusion Criteria: * Severe hypertension (Systolic blood pressure ≥160 mmHg or Diastolic blood pressure ≥100 mmHg) * Current diagnosis of preeclampsia * Active substance use * Serious physical illness (e.g., unable to interact with a smart device) * Enrolled in another home blood pressure monitoring program * Excluded from study participation by their provider * Inability to provide informed consent * Prisoners/institutionalized individuals

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-03.